Delisting risk
Q/C Technologies (QCLS)
Developing silicon-photonic processors for AI inference alongside legacy drug candidates.
$1.95
Pre-market+0.04 (+2.09%)
At close$1.91(−8.61%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions17 holders · as of Mar 31, 2026 | 35.53% | 627.6K shares | |
| Insiders7 holders · as of May 14, 2026 | 37.58% | 663.7K shares | |
| Otherremainder | 26.89% | 474.9K shares |
1.77M company shares as of Aug 22, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
The share count has not been confirmed by a second filing; stakes use it as it stands.
Institutions13F, as of Mar 31, 2026
17 holders · 627.6K shares · 7 new positions · 11 increased · 1 reduced · 8 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Quinn Opportunity Partners LLC | 211.4K | 11.97% | 0 | May 15, 2026 |
| Jane Street Group, LLC | 126.2K | 7.14% | +85.7K | May 12, 2026 |
| UBS Group AG | 78.0K | 4.42% | +60.6K | May 5, 2026 |
| Adar1 Capital Management, LLC | 50.0K | 2.83% | +50.0Knew | May 18, 2026 |
| Geode Capital Management, LLC | 47.4K | 2.68% | +18.1K | May 15, 2026 |
| Vanguard Capital Management LLC | 37.5K | 2.12% | +37.5Knew | May 15, 2026 |
| HRT Financial LP | 22.4K | 1.27% | +22.4Knew | May 14, 2026 |
| Dimensional Fund Advisors LP | 19.1K | 1.08% | 0 | May 7, 2026 |
Ownership statements13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Mar 30, 2026 | Chelsea Sierra Vossdirector | Purchase | 1,753 | $3.15 | 61,555 |
| Sep 4, 2025 | PharmaCyte Biotech, Inc.10 percent owner | Purchase | 889,865 | 889,865 | |
| Nov 14, 2025 | PharmaCyte Biotech, Inc.10 percent owner | Purchase | 889,865 | 889,865 |
CongressHouse and Senate disclosures
Not reported.